GSK3B and diabetic kidney disease: After a series of analyses, the hsa_circRNA_012448-miR-378 g/miR-29b-2-5p-GSK3β network, which is likely to participate in anti-DKD mechanisms through direct and indirect effects, was eventually confirmed to be involved in the action of dapagliflozin against DKD.